videoDetails)

Center's big decision regarding Black Fungus medicines, increase in production of drugs
)
The Drug Controller General of India (DGCI) has approved five pharma companies to start manufacturing the anti-fungal drug Amphotericin B Liposomal Injection, the demand of which has increased in view of the rise in black fungus infection.